Altria seeks FDA marketing order for oral nicotine pouch products
Send a link to a friend
[June 27, 2024]
(Reuters) - Tobacco giant Altria said on Wednesday it had
submitted Premarket Tobacco Product Applications (PMTAs) to the U.S.
Food and Drug Administration for its on! Plus oral nicotine pouch
products.
The FDA had authorized four of Altria's menthol e-cigarette products
last week for sale in the U.S., making them the first ever flavored
vapes the agency has permitted on the market.
On! Plus is a spit-less oral tobacco-derived nicotine pouch. Tobacco
companies have been pushing towards alternatives for traditional tobacco
products amid stricter regulation and greater health awareness among
consumers.
(Reporting by Juveria Tabassum; Editing by Krishna Chandra Eluri)
[to top of second column]
|
![](../images/062724PIX/health1.jpg)
A woman poses with a cigarette in front of Altria logo in this
illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration/File
Photo
![](http://archives.lincolndailynews.com/2024/Jun/27/images/ads/current/peasley_lda_051513.png)
[© 2024 Thomson Reuters. All rights reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |